
<html>
<head>
<title>Retina International's Scientific Newsletter - 11-cis Retinol Dehydrogenase Mutations
</title>
</head>
<body>
<TABLE WIDTH=780  UNIT=PIXELS COLSPEC="L280 L500">
<TR>
<TD><IMG SRC="gif/home/nban2.gif" BORDER=0 ALT="Scientific Newsletter Logo" WIDTH=250 Height=157></TD>
<TD><FONT SIZE=6>
<B>
Retina International's<P>
Scientific Newsletter
</FONT SIZE>
</TD>
</TR>
<TR>
<TD><BR></TD>
<TD><FONT SIZE=7>
Mutation Database<BR>

</FONT SIZE>
<FONT SIZE=8>
Mutations of the 11-cis Retinol Dehydrogenase Gene
</FONT SIZE>
</B>
</TD>
</TR>
</TABLE>

<HR>
<P>
<FONT SIZE=1>
Recent update from: 14.09.2002
</FONT SIZE>
<HR>
<A NAME=top></A>

</TABLE>
<TABLE CELLPADDING=3 BORDER=1 WIDTH=100%>
<TR>
<TH >Phenotype</TH>
<TH>Mutation</TH>
<TH>Basechange</TH>
<TH>Nucleotide</TH>
<TH>Exon</TH>
<TH>Restriction Site</TH>
<TH>Classification<BR>
& Remarks</TH>
<TH>Mutation Database</TH>
<TH>OMIM</TH>
<TH>Reference</TH>
</TR>

<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c035>
Gly 35 Ser
</A>
</TD>
<TD>GGC - AGC</TD>
<TD>103</TD>
<TD>2</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>1085insC/delGAAG
</UL>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(9)>(9)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c043>
128delT
</A>
</TD>
<TD>CGC CTT - CGC C_T</TD>
<TD>128</TD>
<TD>2</TD>
<TD><BR></TD>
<TD>
Homozygous

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(2)>(2)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c072>
216insGTGG
</A>
</TD>
<TD>GTG GCC - GTG GCG TGG C</TD>
<TD>216</TD>
<TD>2</TD>
<TD><BR></TD>
<TD>

Compound:<UL>
<LI>C267W
</UL>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(2)>(2)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c073>
Ser 73 Phe
</A>
</TD>
<TD>TCC - TTC</TD>
<TD>218</TD>
<TD>2</TD>
<TD><BR></TD>
<TD>
Mutation displays reduction in 11cRAl oxidation

</TD>
<TD>
<A HREF="http://www.uwcm.ac.uk/uwcm/mg/ns/1/1391794.html">CM991094</A>
</TD>
<TD>
<A HREF="http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?601617#AllelicVariant0002">601617-0002</A>
</TD>
<TD>
<A HREF=#(10)>(10)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c107>
Gly 107 Arg
</A>
</TD>
<TD>GGT - CGT</TD>
<TD>319</TD>
<TD>3</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>928delCinsGAAG
</UL>Additionally CRD

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(7)>(7)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c132>
Val 132 Met
</A>
</TD>
<TD>GTG - ATG</TD>
<TD>394</TD>
<TD>3</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>R280H
</UL>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(7)>(7)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c157>
Arg 157 Trp
</A>
</TD>
<TD>CGG - TGG</TD>
<TD>468</TD>
<TD>2</TD>
<TD><BR></TD>
<TD>
<UL><LI>Null mutation
<LI>Rod and cone activation sensivity is not affected
<LI>Cone adaptation is slow, recovery biphasic
<LI>0.5% bleach causes monophasic recovery of normal type
<LI>Strong bleaches in partial-bleaches produce delayed recovery

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(1)>(1)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c267>
Cys 267 Trp
</A>
</TD>
<TD>TGC - TGG</TD>
<TD>501</TD>
<TD>5</TD>
<TD><BR></TD>
<TD>

Compound:<UL>
<LI>216ins4bp
</UL>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(2)>(2)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c177>
Val 177 Gly
</A>
</TD>
<TD>GTC - GGC</TD>
<TD>530</TD>
<TD>3</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>R280H
</UL>

</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF="http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?601617#AllelicVariant0005">601617-0005</A>
</TD>
<TD>
<A HREF=#(5)>(5)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c238>
Gly 238 Trp
</A>
</TD>
<TD>GGG - TGG</TD>
<TD>712</TD>
<TD>4</TD>
<TD><BR></TD>
<TD>
Homozygous<BR>
Mutation displays reduction in 11cRAl oxidation

</TD>
<TD>
<A HREF="http://www.uwcm.ac.uk/uwcm/mg/ns/1/1391794.html">CM991095</A>
</TD>
<TD>
<A HREF="http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?601617#AllelicVariant0001">601617-0001</A>
</TD>
<TD>
<A HREF=#(10)>(10)</A>
<BR><A HREF=#(3)>(3)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c238>
712insG
</A>
</TD>
<TD>TAT GGG GGG GCC - TAT GGG GGG GGC C</TD>
<TD>712</TD>
<TD>4</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>Y281H
</UL>
<BR>Additionally CRD

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(7)>(7)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c280>
Arg 280 His
</A>
</TD>
<TD>CGC - CAC</TD>
<TD>839</TD>
<TD>5</TD>
<TD><BR></TD>
<TD>
Homozygous:<UL>
<LI>No visual field loss
<LI>Low ERG amplitude
<LI>ERG recovery after 3 h
<LI>DA: Elevated threshold for rod adaptation
</UL>

Compound:<UL>
<LI>A294P
<LI>V132M
<LI>928delCinsGAAG
<LI>V177G
</UL>

</TD>
<TD>
<A HREF="http://www.uwcm.ac.uk/uwcm/mg/ns/1/1391794.html">CM993460</A>
</TD>
<TD>
<A HREF="http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?601617#AllelicVariant0003">601617-0003</A>
</TD>
<TD>
<A HREF=#(3)>(3)</A>
<BR><A HREF=#(5)>(5)</A>
<BR><A HREF=#(6)>(6)</A>
<BR><A HREF=#(7)>(7)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c281>
Tyr 281 His
</A>
</TD>
<TD>CTA - CCA</TD>
<TD>841</TD>
<TD>5</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>719insG
</UL>
Additionally CRD

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(7)>(7)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c294>
Ala 294 Pro
</A>
</TD>
<TD>GCC - CCC</TD>
<TD>880</TD>
<TD>5</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>R280H
</UL>

</TD>
<TD>
<A HREF="http://www.uwcm.ac.uk/uwcm/mg/ns/1/1391794.html">CM993461</A>
</TD>
<TD>
<A HREF="http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?601617#AllelicVariant0004">601617-0004</A>
</TD>
<TD>
<A HREF=#(3)>(3)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus</TD>
<TD>
<A NAME=c310>
928delCinsGAAG
</A>
</TD>
<TD>GTC CTT - GTC GAA GTT</TD>
<TD>928</TD>
<TD>5</TD>
<TD><BR></TD>
<TD>
Compound:<UL>
<LI>G107R
<LI>R280H
<LI>G35S
</UL>
4 patients with additional CRD

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(7)>(7)</A>
<BR><A HREF=#(9)>(9)</A>

</TD>
</TR>


<TR>
<TD>Fundus albipunctatus + COD</TD>
<TD>
<A NAME=c035>
Gly 35 Ser
</A>
</TD>
<TD>GGC - AGC</TD>
<TD>103</TD>
<TD>2</TD>
<TD><BR></TD>
<TD>
Homozygous<UL>
<LI>Consanguineous
<LI>First Gly of a co-factor-binding domain
</UL>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(8)>(8)</A>

</TD>
</TR>


<TR>
<TD>Polymorphism</TD>
<TD>
<A NAME=c033>
Ile 33 Val
</A>
</TD>
<TD>ATC - GTC</TD>
<TD>097</TD>
<TD>2</TD>
<TD><BR></TD>
<TD>
<BR>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(10)>(10)</A>

</TD>
</TR>


<TR>
<TD>Polymorphism</TD>
<TD>
<A NAME=c141>
Ser 141 Ser
</A>
</TD>
<TD>ATC - ATT</TD>
<TD>423</TD>
<TD>3</TD>
<TD><BR></TD>
<TD>
<BR>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(10)>(10)</A>

</TD>
</TR>


<TR>
<TD>Polymorphism</TD>
<TD>
<A NAME=c200>
Val 200 Val
</A>
</TD>
<TD><BR></TD>
<TD>600</TD>
<TD>4</TD>
<TD><BR></TD>
<TD>
<BR>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<A HREF=#(4)>(4)</A>
<BR><A HREF=#(10)>(10)</A>

</TD>
</TR>


<TR>
<TD>Sequence</TD>
<TD>
<A NAME=c0>
<BR>
</A>
</TD>
<TD><BR></TD>
<TD><BR></TD>
<TD><BR></TD>
<TD><BR></TD>
<TD>
<A HREF="sequence/rdh5seq.doc">The sequence data are adjusted to a sequence given in a WORD file which can be downloaded here. Nucleotides are counted from the translation start site as used in most of the recent publications of RDH5 mutations.</A>

</TD>
<TD>
<BR>
</TD>
<TD>
<BR>
</TD>
<TD>
<BR>

</TD>
</TR>





</TABLE>



<P ALIGN=CENTER>
<FONT SIZE=5>
<B>
References
</B>
</FONT SIZE>

<P>
<FONT SIZE=3>
<OL>


<A NAME=(1)></A><LI>	 Cideciyan,A.V., Haeseleer,F., Aleman,T.S., Jang,G., Verlinde,C.L.M.J., Marmor,M.F., Jacobson,S.G., and Palczewski,K. Rod plateaux during dark adaptation in fundus albipunctatus caused by a null mutation in the 11-cis-retinol dehydrogenase gene. 2000; Invest.Ophthalm.Vis.Sci. 41:  S532 <BR><A HREF=#top>Goto Top</A><P>
<A NAME=(2)></A><LI>	 Driessen,C.A., Janssen,B.P., Winkens,H.J., Kuhlmann,L.D., van Vugt,A.H., Pinckers,A.J., Deutman,A.F., and Janssen,J.J. Null mutation in the human 11-cis retinol dehydrogenase gene associated with fundus albipunctatus. 2001; Ophthalmology. 108:  1479-1484.<BR><A HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21363995&form=6&db=m&Dopt=b">Link to PubMed</A><BR><A HREF=#top>Goto Top</A><P>
<A NAME=(3)></A><LI>	 Gonzalez-Fernandez,F., Kurz,D., Bao,Y., Newman,S., Conway,B.P., Young,J.E., Han,D.P., and Khani,S.C. 11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus. 1999; Mol.Vis. 5:  41 <BR><A HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20085373&form=6&db=m&Dopt=b">Link to PubMed</A><BR><A HREF=#top>Goto Top</A><P>
<A NAME=(4)></A><LI>	 Harris,E.W., Seddon,J.M., and Dryja,T.P. Analysis Of The Gene Encoding 11-ci-Retinol Dehydrogenase In Patients With Age Related Macular Degeneration. 1997; Invest.Ophthalmol.Vis.Sci. 38:  S800 <BR><A HREF=#top>Goto Top</A><P>
<A NAME=(5)></A><LI>	 Kuroiwa,S., Kikuchi,T., and Yoshimura,N. A novel compound heterozygous mutation in the RDH5 gene in a patient with fundus albipunctatus. 2000; Am.J.Ophthalmol. 130:  672-675.<BR><A HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20532265&form=6&db=m&Dopt=b">Link to PubMed</A><BR><A HREF=#top>Goto Top</A><P>
<A NAME=(6)></A><LI>	 Miyazaki,K., Murakami,A., Imamura,S., Yoshii,M., Ishida,M., Washio,N., and Okisaka,S. [A case of fundus albipunctatus with a retinol dehydrogenase 5 gene mutation in a child]. 2001; Nippon Ganka Gakkai Zasshi. 105:  530-534.<BR><A HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21442798&form=6&db=m&Dopt=b">Link to PubMed</A><BR><A HREF=#top>Goto Top</A><P>
<A NAME=(7)></A><LI>	 Nakamura,M., Hotta,Y., Tanikawa,A., Terasaki,H., and Miyake,Y. A high association with cone dystrophy in fundus albipunctatus caused by mutations of the RDH5 gene. 2000; Invest Ophthalmol.Vis.Sci. 41:  3925-3932.<BR><A HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20507720&form=6&db=m&Dopt=b">Link to PubMed</A><BR><A HREF=#top>Goto Top</A><P>
<A NAME=(8)></A><LI>	 Wada,Y., Abe,T., Sato,H., and Tamai,M. A novel Gly35Ser mutation in the RDH5 gene in a Japanese family with fundus albipunctatus associated with cone dystrophy. 2001; Arch.Ophthalmol. 119:  1059-1063.<BR><A HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21341510&form=6&db=m&Dopt=b">Link to PubMed</A><BR><A HREF=#top>Goto Top</A><P>
<A NAME=(9)></A><LI>	 Wada,Y., Nakazawa,M., Abe,T., Fuse,N., and Tamai,M. Clinical variability of patients associated with gene mutations of visual cycle protein; Arrestin, RPE65 and RDH5 genes. 2000; Invest.Ophthalm.Vis.Sci. 41:  S617 <BR><A HREF=#top>Goto Top</A><P>
<A NAME=(10)></A><LI>	 Yamamoto,H., Simon,A., Eriksson,U., Harris,E., Berson,E.L., and Dryja,T.P. Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. 1999; Nat.Genet. 22:  188-191.<BR><A HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=99295938&form=6&db=m&Dopt=b">Link to PubMed</A><BR><A HREF=#top>Goto Top</A><P>

</OL>

</FONT SIZE>

<HR>
<TABLE UNITS=PIXEL WIDTH=780 COLSPEC="C200 R200 R480" >
<TR>
<TD>
<A HREF="index.htm">
<IMG SRC="gif/home/nban2.gif" ALIGN=LEFT WIDTH=115 HEIGTH=105 BORDER=0>
</A>
</TD>
<TD>
<A HREF="index.htm"><FONT SIZE=4>
Return to Retina International's<BR>
Scientific Newsletter
</FONT SIZE>
</A>
</TD>
<TD><A HREF="mutation.htm"><FONT SIZE=4>
Return to <BR>
Mutation Database Page
</FONT SIZE>
</A>
</TD>
<TD>
<A HREF="#top"><FONT SIZE=4>
Return to pagehead</FONT SIZE>
</A>
</TD>
</TR>
<TR>
<TD>
<A HREF=mailto:markus.preising@retina-international.org>
<IMG SRC="gif/home/mp.gif" ALIGN=LEFT WIDTH=100 HEIGTH=117 BORDER=0>
<BR CLEAR=LEFT>
Contact the editor </A>
</TD>
<TD><A HREF="database.htm"><FONT SIZE=4>
Return to<BR>
Database Page
</FONT SIZE>
</A>
</TD>
<TD COLSPAN=2>
<FONT SIZE=2>
This site is maintained and edited by
</FONT SIZE>
<FONT SIZE=1>
<BR>
Dr. rer. medic. Markus Preising, Dipl.Biol.
<BR>
Molecular Genetics Laboratory
<BR>
Department of Paediatric Ophthalmology, Strabismology and Ophthalmogenetics
<BR>
University of Regensburg
<BR>
Head: Prof. Dr. med. Birgit Lorenz
</FONT SIZE>
</TD>
</TR>
</TABLE>
</body>
</html>


